New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions
{{output}}
Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease characterized by late-stage manifestation and relative resistance to standard therapies. Challenges with early detection and a paucity of effective therapies lead to one of the lowest 5-year survival ... ...
